High levels of serum CA15‐3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non‐pathological complete response after neoadjuvant chemotherapy

Journal of Surgical Oncology, EarlyView.


https://ift.tt/2tDEy94